Pharmafile Logo
Pharmafocus logo
Advanced Search

Boehringer scoops schizophrenia candidates for €627.5m

December 19, 2017
Manufacturing and Production, Sales and Marketing Autifony, Boehringer Ingelheim, biotech, drugs, pharma, pharmaceutical

Boehringer Ingelheim has moved early to secure an exclusive option on Autifony’s lead candidate for the treatment of schizophrenia, AUT00206, …

News
homeopathy-1063292_640

FDA pledges to crack down on homeopathy treatments

December 19, 2017
Manufacturing and Production, Sales and Marketing FDA homeopathy, US, pharma

Following in the steps of authorities in the European Union, Australia and the United Kingdom, the FDA has pledged to …

News
doctor-563428_960_720

100,000 vacancies contribute to NHS crisis

December 19, 2017
Manufacturing and Production, Medical Communications NHS, UK, biotech, drugs, nurses, pharma, pharmaceutical

Warning shots have been fired by both the General Medical Council (GMC) and the Labour Party about the recruitment issues …

News
novartis_window

Novartis snaps up Priority Review Voucher for $130m

December 18, 2017
Manufacturing and Production, Sales and Marketing Novartis, Ultragenyx, biotech, drugs, pharma, pharmaceutical

Novartis has got its wallet out to pick up a Priority Review Voucher (PRV) from Ultragenyx, forking out $130 million …

News
rare-disease-2888820_960_720

Rare disease medicines access faces a perfect storm

December 18, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, rare disease

With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the …

Feature

FDA approves Pfizer’s Xeljanz for psoriatic arthritis

December 18, 2017
Sales and Marketing FDA, Pfizer, Xeljanz, pharma, psoriatic arthritis

Pfizer has revealed that the FDA has passed marketing approval for Xeljanz (tofacitinib) for the treatment of active psoriatic arthritis …

News
apotex_web

Apotex founder found dead at home

December 18, 2017
Medical Communications, Sales and Marketing Apotex, biotech, drugs, pharma, pharmaceutical

Apotex, the world’s seventh largest generics manufacturer, has lost its Chairman and founder, after Barry Sherman and his wife, Honey, …

News
boehringer_biberach_germany_copy

Boehringer loses CFO over financial strategy dispute

December 18, 2017
Medical Communications, Sales and Marketing Boehringer, Boehringer Ingelheim, appointment, pharma

Boehringer Ingelheim is set to part ways with its Chief Financial Officer Simone Menne after 16 months due to fundamental …

News
merckwindowweb

Keytruda falls hard at gastric cancer hurdle

December 18, 2017
Research and Development, Sales and Marketing MSD, biotech, drugs, keytruda, pharma, pharmaceutical

There was a time when PD-1/L1 immunotherapy treatments could do no wrong, blasting through indication after indication. However, the limits …

News
tesaro

New PARP inhibitor hits UK market, offering distinct advantage

December 18, 2017
Sales and Marketing AstraZeneca, Novartis, Tesaro, Zejula, biotech, drugs, lynparza, pharma, pharmaceutical

Tesaro’s Zejula has been launched in the UK but availability on the NHS has still not been decided. The PARP …

News
celgene_exteriors-3

Cancer Research UK agrees largest drug discovery collab to date

December 15, 2017
Medical Communications, Research and Development Cancer Research UK, Celgene, biotech, drugs, pharma, pharmaceutical

Cancer Research UK has announced that its subsidiary, Cancer Research Technology (CRT), and Celgene have agreed a drug discovery collaboration. …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ionis, Sanofi, Teva, haemophilia, pharma, top ten

Just 10 days away from Christmas, and big news is still flowing in the industry. Sanofi remains embroiled in scandal …

News
teva_copy

Fierce local opposition to Teva’s restructure efforts

December 15, 2017
Manufacturing and Production, Medical Communications Teva, biotech, drugs, pharma, pharmaceutical

When Kare Shultz decided to take on the CEO position at Teva he would have known that he was setting …

News
bruno-strigini-image

Novartis’ President of Oncology announces retirement

December 15, 2017
Medical Communications Bruno Strigini, Novartis, pharma

Novartis has announced that the President of its oncology business, Bruno Strigini, is to retire next year, citing personal reasons …

News

BMS partners again with the company behind Opdivo

December 14, 2017
Medical Communications, Sales and Marketing Bristol-Myers Squibb, biotech, drugs, opdivo, pharma, pharmaceutical

Bristol-Myers Squibb has once again struck a deal with Ono Pharmaceutical for multiple programs, seeking to discover a boost to …

News
shutterstock_138095450

Novartis, Abbott targeted by Indian watchdog over allegations of price collusion

December 14, 2017
Sales and Marketing Abbott, Emcure Pharma, Galdus, Novartis, USV, diabetes, pharma, vildagliptin

Novartis, Abbott, Emcure Pharma and USV have become the targets of an investigation by the Competition Commission of India (CCI) …

News
fullsizerender_2_rav

Working Life: Dr Rav Seeruthun, Medical Director of Roche UK

December 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

Pharmafile.com sat down with Dr Rav Seeruthun, Medical Director of Roche UK, to discuss his career thus far and the lessons …

Feature
bacteria-1777339_960_720

FDA launches new method for antibiotic prescription

December 14, 2017
Medical Communications antibiotic resistance, biotech, drugs, pharma, pharmaceutical

The fight against the growth of antibiotic resistance has become a major talking point internationally in recent years and the …

News
blood-75301_640

‘Mind-blowing’ gene therapy could herald a cure for haemophilia, study shows

December 14, 2017
Research and Development haemophilia, pharma

A team of clinical researchers at Barts Health NHS Trust and Queen Mary University of London have reported that a …

News

What will Pfizer do with its second Remicade biosimilar?

December 14, 2017
Sales and Marketing Ixifi, Johnson & Johnson, Pfizer, Remicade, biosimilars, biotech, drugs, inflectra, pharma, pharmaceutical

Pfizer is now in the unusual position of owning two biosimilars to Johnson & Johnson’s Remicade, though one of these …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026